Updates

SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD HIKE SENIOR PREMIUMS, BOOST DRUG COMPANY PROFITS

Jul 22, 2021

Big Pharma Wants Implementation of Misguided Policy that Does Nothing to Lower Read More

THEY SAID IT! U.S. SENATE JUDICIARY SUBCOMMITTEE HIGHLIGHTS BIG PHARMA’S ANTI-COMPETITIVE PRACTICES

Jul 14, 2021

Lawmakers Showcase How Big Pharma’s Patent Abuse Drives Out-of-Control Read More

DOSE OF REALITY: LAWMAKERS TO PROBE BIG PHARMA PATENT ABUSE AS INNOVATION EXCUSES CRUMBLE

Jul 13, 2021

U.S. Senate Judiciary Subcommittee Hearing Tuesday Will Build on Momentum for Read More

CSRxP COMMENDS PRESIDENT BIDEN FOR RENEWED COMMITMENT TO HOLDING BIG PHARMA ACCOUNTABLE

Jul 9, 2021

Campaign Looks Forward to Working with Administration and Congress to Crack Read More

CSRXP: OVERSIGHT REPORT ADDS TO MOMENTUM IN WASHINGTON TO HOLD BIG PHARMA ACCOUNTABLE

Jul 8, 2021

U.S. House Oversight & Reform Committee Report Shines Light on Branded Read More

BIG PHARMA WATCH: JULY PRICE HIKES CLIMB TO 52

Jul 7, 2021

Brand Name Drug Companies Stick to Business-as-Usual in Third Major Round of Read More

CSRxP: Big Pharma Flaunts Disregard for Rx Affordability With Third Major Round of Pandemic Price Hikes

Jul 1, 2021

Pharmaceutical Companies Increase Prices on 32 Brand Name Drugs to Start July Read More

ICYMI: BIG PHARMA USES INFLUENCE OVER PATIENT GROUPS & ASTROTURF TACTICS TO UNDERMINE RX SOLUTIONS

Jun 30, 2021

New Report Reveals “Hidden Hand” Of Brand Name Drug Industry In case you Read More

CSRXP APPLAUDS U.S. HOUSE PROBE INTO BIOGEN PRICING OF ADUHELM

Jun 25, 2021

Pallone and Maloney Announce Joint Investigation into Massive Price Tag on Read More

BIG PHARMA WATCH: HEADLINES SHOW BIOGEN ADHUHELM PRICING HAS REIGNITED URGENCY TO HOLD BIG PHARMA ACCOUNTABLE

Jun 25, 2021

Coverage Highlights Backlash Over Massive Price Tag for Unproven Treatment, Read More

SECOND OPINION: PFIZER’S PHONY CALL FOR LOWER DRUG COSTS

Jun 22, 2021

CEO Sidesteps Big Pharma’s Pricing Practices; Pushes Proposals That Would Read More

CSRXP: WYDEN RX PRICING PRINCIPLES ADD TO MOMENTUM IN WASHINGTON TO HOLD BIG PHARMA ACCOUNTABLE

Jun 22, 2021

Lawmakers Must Advance Solutions to Lower Drug Prices  Washington, Read More